VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
9.08 CAD
-0.53 (-5.52%)
VHI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.76%, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
VHI has a better Return On Equity (1.08%) than 87.50% of its industry peers.
VHI has a better Return On Invested Capital (2.86%) than 100.00% of its industry peers.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI has a Profit Margin of 2.88%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
The Operating Margin of VHI (12.47%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VHI has grown nicely.
The Gross Margin of VHI (80.92%) is better than 100.00% of its industry peers.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VHI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VHI has been increased compared to 5 years ago.
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.82 indicates that VHI is not in any danger for bankruptcy at the moment.
VHI's Altman-Z score of 3.82 is fine compared to the rest of the industry. VHI outperforms 62.50% of its industry peers.
The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.13, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI's Debt to Equity ratio of 0.00 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.82 |
ROIC/WACC0.34
WACC8.47%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.94, VHI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
VHI's Quick ratio of 1.94 is fine compared to the rest of the industry. VHI outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.34%.
VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.88% yearly.
Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.14% on average per year.
EPS Next Y-2.2%
EPS Next 2Y99.19%
EPS Next 3Y78.88%
EPS Next 5YN/A
Revenue Next Year59.37%
Revenue Next 2Y38.13%
Revenue Next 3Y27.14%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 151.33, the valuation of VHI can be described as expensive.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.34.
With a Price/Forward Earnings ratio of 32.69, VHI can be considered very expensive at the moment.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (23.56), we can say VHI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.33 | ||
| Fwd PE | 32.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.04 | ||
| EV/EBITDA | 20.66 |
4.3 Compensation for Growth
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 78.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.19%
EPS Next 3Y78.88%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (12/8/2025, 7:00:00 PM)
9.08
-0.53 (-5.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners33.83%
Inst Owner ChangeN/A
Ins Owners11.38%
Ins Owner ChangeN/A
Market Cap573.13M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (70.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-1.47%
PT rev (3m)-2.08%
EPS NQ rev (1m)-15.79%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)-41.9%
EPS NY rev (3m)-49.32%
Revenue NQ rev (1m)3.74%
Revenue NQ rev (3m)4.53%
Revenue NY rev (1m)3.96%
Revenue NY rev (3m)7.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.33 | ||
| Fwd PE | 32.69 | ||
| P/S | 5.84 | ||
| P/FCF | 47.04 | ||
| P/OCF | 44.36 | ||
| P/B | 2.19 | ||
| P/tB | 11.64 | ||
| EV/EBITDA | 20.66 |
EPS(TTM)0.06
EY0.66%
EPS(NY)0.28
Fwd EY3.06%
FCF(TTM)0.19
FCFY2.13%
OCF(TTM)0.2
OCFY2.25%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.82 |
F-Score3
WACC8.47%
ROIC/WACC0.34
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-2.2%
EPS Next 2Y99.19%
EPS Next 3Y78.88%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year59.37%
Revenue Next 2Y38.13%
Revenue Next 3Y27.14%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year75.9%
EBIT Next 3Y39.84%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 151.33 and the Price/Book (PB) ratio is 2.19.